Hemophilia is a group of diseases in which blood does not clot normally. Factors in blood are involved in clotting. Hemophiliacs lacking the normal Factor VIII are said to have Hemophilia A, the most common form. Normal Factor VIII can be supplied at a high dollar and health risk cost, although the development of biotechnologically engineered Factor VIII produced by bacteria lessens the health risk. England's Queen Victoria was a carrier for this disease. The allele was passed to two of her daughters and one son. Since royal families in Europe commonly intermarried, the allele spread, and may have contributed to the downfall of the Russian monarchy (Czar Nicholas' son Alexei suffered from hemophilia A inherited from his mother who carried Victoria's genetic secret).
Muscular dystrophy is a term encompassing a variety of muscle wasting diseases. The most common type, Duchenne Muscular Dystrophy (DMD), affects cardiac and skeletal muscle, as well as some mental functions. DMD is an X-linked recessive occurring in 1 in 3500 newborns. Most sufferers die before their 20th birthday. In 1987, Louis Kunkel claimed to have isolated a protein, dystrophin, present in normal individuals (about 0.002 % of their muscle protein) but absent in two individuals with DMD. The lack of dystrophin is accompanied with a condition of muscle hardening known as fibrosis, which restricts blood supply to the muscle which then die. The gene technologies discussed in an earlier chapter have been employed to sequence and clone the dystrophin gene, which is the largest known human gene (some 2-3 million base pairs), with 60 exons and many large introns.
No comments:
Post a Comment